August 24, 2020
Yield10 Bioscience announces pricing of $5.2 million public offering and concurrent private placement
Yield10 Bioscience announces proposed public offering of common stock and concurrent private placement
August 17, 2020
Yield10 Bioscience obtains positive response from USDA-APHIS on regulated Status of its CRISPR genome-edited C3007 trait in canola; Plans U.S. field tests for 2021
August 11, 2020
Yield10 Bioscience announces second quarter 2020 financial results
Yield10 Bioscience signs research agreement with GDM to evaluate new yield traits in soybean
August 5, 2020
Yield10 Bioscience announces spring planting of 50 acres of wild-type spring camelina to support business development plans
August 4, 2020
Yield10 Bioscience announces successful evaluation of emergence and establishment in field tests of winter camelina varieties
July 6, 2020
Should regenerative agriculture embrace gene editing? Yield10 Bioscience says it must (AgFunder News)
June 17, 2020
Yield10 Bioscience begins 2020 field test program to evaluate novel yield traits in camelina and canola
May 14, 2020
Yield10 Bioscience announces first quarter 2020 financial results
Yield10 Bioscience secures regulatory permits for U.S. and Canadian sites and announces plans for 2020 field test program in camelina and canola
May 7, 2020
An oilseed’s forward progress is good news for CRISPR - Can the momentum be maintained? (CropLife)
April 27, 2020
Yield10 Bioscience obtains positive response from USDA-APHIS on regulatory status of its CRISPR genome-edited C3007 trait in camelina, paving the way for U.S. field tests
March 19, 2020
Yield10 Bioscience announces fourth quarter and full year 2019 financial results
Yield10 Bioscience announces results of 2019 field test program
March 10, 2020
Yield10 Bioscience achieves key milestones in early development program in corn to evaluate novel traits
February 13, 2020
Yield10 Bioscience appoints agriculture industry veteran Sherri M. Brown, Ph.D., to board of directors
January 31, 2020
Yield10 Bioscience regains compliance with Nasdaq Minimum Bid Price Listing requirement
January 16, 2020
Yield10 Bioscience submits "Am I Regulated?" letter to USDA-APHIS BRS for CRISPR genome-edited C3007 in camelina to pave the way for U.S. field tests
January 15, 2020
Yield10 Bioscience announces 1-for-40 reverse stock split
December 18, 2019
GMO and genome editing science continues to advance despite continued skepticism (AgriBusiness Global)
November 20, 2019
Yield10 Bioscience announces closing of $11.5 million equity offering and full exercise of over-allotment option
November 15, 2019
Yield10 Bioscience announces pricing of $10.75 million equity offering
November 12, 2019
Yield10 Bioscience announces third quarter 2019 financial results
October 23, 2019
Yield10 Bioscience signs research agreement with J. R. Simplot to evaluate new traits to produce high yielding, sustainable potato crop
August 19, 2019
Yield10 Bioscience expands research license with Bayer for evaluation of a novel C3004 yield trait gene in soybean
August 13, 2019
Yield10 Bioscience announces second quarter 2019 financial results
August 12, 2019
Yield10 Bioscience announces Notice of Allowance for U.S. patent covering crop yield trait C4001
August 5, 2019
Yield10 Bioscience granted U.S. patent covering crop yield trait C3003
June 25, 2019
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to highlight unique aspects of the company’s GRAIN technology platform to identify novel traits for crops at the 3rd Precision CRISPR & NBT AgBio Congress
http://www.yield10bio.com
Copyright @ 1992-2025 SeedQuest - All rights reserved